Clorox (CLX) — insider trading
Consumer Staples
Clorox (CLX) has 18 reported SEC Form 4 insider transactions in our data, including 1 open-market purchase among the most recent 18 (latest 2026-06-30).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | Breber Pierre R | Director | Grant / award / vesting (derivative) | 354 | $0.00 | $0 | Form 4 |
| 2026-06-30 | Shattock Matthew J | Director | Grant / award / vesting (derivative) | 550 | $0.00 | $0 | Form 4 |
| 2026-06-30 | Plaines Stephanie | Director | Grant / award / vesting (derivative) | 288 | $0.00 | $0 | Form 4 |
| 2026-06-30 | WEINER RUSSELL J | Director | Grant / award / vesting (derivative) | 354 | $0.00 | $0 | Form 4 |
| 2026-06-30 | WILLIAMS CHRISTOPHER J | Director | Grant / award / vesting (derivative) | 288 | $0.00 | $0 | Form 4 |
| 2026-06-17 | Hyder Chris T | Officer (EVP-Chief Operating Officer) | Grant / award / vesting | 42,118 | $94.97 | $4.00M | Form 4 |
| 2026-06-17 | Marriner Kirsten | Officer (EVP - Chief Admin Officer) | Grant / award / vesting | 26,324 | $94.97 | $2.50M | Form 4 |
| 2026-06-17 | Hilt Angela C | Officer (EVP - Chief Legal Officer) | Grant / award / vesting | 26,324 | $94.97 | $2.50M | Form 4 |
| 2026-06-17 | Bellet Luc | Officer (EVP - Chief Financial Officer) | Grant / award / vesting | 42,118 | $94.97 | $4.00M | Form 4 |
| 2026-05-08 | Breber Pierre R | Director | Grant / award / vesting (derivative) | 42 | $0.00 | $0 | Form 4 |
| 2026-05-08 | Shattock Matthew J | Director | Grant / award / vesting (derivative) | 271 | $0.00 | $0 | Form 4 |
| 2026-05-08 | Plaines Stephanie | Director | Grant / award / vesting (derivative) | 104 | $0.00 | $0 | Form 4 |
| 2026-05-08 | WEINER RUSSELL J | Director | Grant / award / vesting (derivative) | 242 | $0.00 | $0 | Form 4 |
| 2026-05-08 | WILLIAMS CHRISTOPHER J | Director | Grant / award / vesting (derivative) | 297 | $0.00 | $0 | Form 4 |
| 2026-05-05 | Breber Pierre R | Director | Open-market purchase | 5,000 | $85.82 | $429.1K | Form 4 |
| 2026-04-01 | Bellet Luc | Officer (EVP - Chief Financial Officer) | Shares withheld for taxes / exercise cost | 244 | $103.63 | $25.3K | Form 4 |
| 2026-03-31 | WILLIAMS CHRISTOPHER J | Director | Grant / award / vesting (derivative) | 265 | $0.00 | $0 | Form 4 |
| 2026-02-13 | WILLIAMS CHRISTOPHER J | Director | Grant / award / vesting (derivative) | 213 | $0.00 | $0 | Form 4 |
Ask the chat about CLX's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Clorox (CLX).
Last updated 2026-06-30 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.